A piece of news
Peptomyc has been recognized in the Johnson & Johnson Innovation Start-up Slam Barcelona and Transplant Biomedicals, Mowoot and Braingaze, in Biocat’s HealthTech Start-up Competition
Catalan biotechnology start-up Peptomyc, a spin-off of ICREA and the Vall d’Hebron Institute of Oncology (VHIO) led by Laura Soucek, won the Johnson & Johnson Innovation Start-up Slam Barcelona at BIO-Europe Spring. The event was held on 21 March at the CCiB in Barcelona, with roughly 200 participants.
The company was chosen from 14 start-ups that participated in the competition, including 4 Catalan firms (Peptomyc, IDP Pharma, Leukos Biotech and Iproteos). The company’s prize is mentoring and guidance from Johnson & Johnson.
However, they aren’t the only Catalan start-up to be recognized in pitching competitions at BIO-Europe Spring. Transplant Biomedicals, Mowoot and Braingaze won first, second and third, respectively, in the HealthTech Start-up Competition, held on 22 March. Transplant Biomedicals, presented by CEO Ignasi Heras, won €5,000, 4 hours of mentoring from Alta Life Sciences and 10 hours of legal advice form RCD.
Peptomyc is working to develop a new oncology treatment based on inhibiting the Myc protein, which is the most aggressive oncogene in cancer. In her presentation at the Start-up Slam, Laura Soucek explained that the company is looking to raise €10 millions to complete preclinical development and begin phase I/II clinical trials. They have already raised €1 million in private investment and €2 millions in public grants.
Transplant Biomedicals, which has just raised €2.5 millions in a round of funding led by Caixa Capital Risc and Kereon Partners, is developing a new device to improve the quality and viability of transplant organs during transport, specifically kidneys and livers.
Mowoot, the first start-up created out of the d·HEALTH Barcelona master, Biocat’s main program to accelerate entrepreneurship in healthcare, is marketing a non-invasive non-farmacologic medical device to combat chronic constipation. The belt-like device imitates colon massage to alleviate this condition, mainly in patients that have suffered a stroke, spinal injuries, multiple sclerosis or Parkinson, among others.
Braingaze was founded in 2013 and has developed a platform to diagnose, monitor and treat common cognitive disorders like ADHD, dyslexia, autism and Alzheimer using neurobiological markers and artificial intelligence.
The entrepreneurial sector was represented at BIO-Europe Spring in two pitching competitions with a total of 24 participating start-ups, 14 of which were Catalan. The companies that participated in Start-up Slam Barcelona were Vaxxit, IDP Discovery Pharma, Junction Therapeutics, TILT Biotherapeutics, Oxford Endovascular, Oncostellae, Leukos Biotech, Oppilotech, Aligen Therapeutics, Epical Biosciences, MicroQuin, vitalityDNA, Peptomyc and Iproteos. They each gave a brief three-minute pitch to the panel of judges: Antonio Gomez, of Johnson & Johnson Innovation; Nerida Scott, of Johnson & Johnson Innovation; Joris de Maeyer, venture coach at Bioqube Ventures; Karen Wagner, partner at Ysios Capital; and Montserrat Vendrell, partner at Alta Life Sciences.
The 10 start-ups selected for the HealthTech Start-up Competition were Adan MI, Braingaze, Butler Scientifics, HealthApp, Made of Genes, MJN, Mowoot, Qrem, TBioMed and Transplant Biomedicals. They each gave a brief five-minute pitch to the panel of judges: Montserrat Vendrell, partner at Alta Life Sciences; Oscar Alegre, consultant at RCD; Jorge Juan Fernández, director of e-Health and Health 2.0 at Hospital Sant Joan de Déu and academic director of Moebio; and Frederic Llordachs, co-founder of Doctoralia.
Start-up Slam Barcelona was organized by the EBD Group with sponsorship from Johnson & Johnson Innovation and collaboration from Biocat, Innovation Forum and Plug&Play. The HealthTech Start-up Competition was organized by Biocat and sponsored by Alta Life Sciences and RCD.